BDTX
Price
$2.02
Change
-$0.15 (-6.91%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
123.39M
83 days until earnings call
OXBDF
Price
$3.93
Change
-$0.02 (-0.51%)
Updated
May 2 closing price
Capitalization
435.42M
Interact to see
Advertisement

BDTX vs OXBDF

Header iconBDTX vs OXBDF Comparison
Open Charts BDTX vs OXBDFBanner chart's image
Black Diamond Therapeutics
Price$2.02
Change-$0.15 (-6.91%)
Volume$8.93K
Capitalization123.39M
Oxford Biomedica
Price$3.93
Change-$0.02 (-0.51%)
Volume$2K
Capitalization435.42M
BDTX vs OXBDF Comparison Chart
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. OXBDF commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and OXBDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (BDTX: $2.03 vs. OXBDF: $3.93)
Brand notoriety: BDTX and OXBDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 23% vs. OXBDF: 9%
Market capitalization -- BDTX: $123.39M vs. OXBDF: $435.42M
BDTX [@Biotechnology] is valued at $123.39M. OXBDF’s [@Biotechnology] market capitalization is $435.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileOXBDF’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • OXBDF’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than OXBDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 6 TA indicator(s) are bullish.

  • BDTX’s TA Score: 6 bullish, 4 bearish.

Price Growth

BDTX (@Biotechnology) experienced а +7.41% price change this week, while OXBDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($435M) has a higher market cap than BDTX($123M). BDTX YTD gains are higher at: -5.140 vs. OXBDF (-27.218).
BDTXOXBDFBDTX / OXBDF
Capitalization123M435M28%
EBITDA-78.44MN/A-
Gain YTD-5.140-27.21819%
P/E Ratio33.83N/A-
Revenue0N/A-
Total Cash98.6MN/A-
Total Debt22.2MN/A-
FUNDAMENTALS RATINGS
OXBDF: Fundamental Ratings
OXBDF
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBKCF0.11N/A
+2.50%
BIGG Digital Assets Inc.
ENGGY7.740.10
+1.31%
Enagas S.A.
SAGYX137.56N/A
N/A
ClearBridge Growth I
SMCAY18.97-0.29
-1.51%
SMC Corp
SMPNY14.53-1.72
-10.58%
Sompo Hldgs Inc

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with CCCC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-6.45%
CCCC - BDTX
47%
Loosely correlated
-8.11%
NTLA - BDTX
46%
Loosely correlated
-4.86%
BEAM - BDTX
46%
Loosely correlated
-2.99%
ITOS - BDTX
45%
Loosely correlated
-1.56%
CRSP - BDTX
44%
Loosely correlated
-5.76%
More

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and IMMP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and IMMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
IMMP - OXBDF
23%
Poorly correlated
-3.48%
BPMC - OXBDF
21%
Poorly correlated
-1.45%
BDTX - OXBDF
21%
Poorly correlated
-6.45%
ATNM - OXBDF
21%
Poorly correlated
-6.56%
UBX - OXBDF
20%
Poorly correlated
-4.90%
More